Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes

Patients with type 2 diabetes mellitus have a twofold increased risk of cardiovascular mortality compared with non-diabetic individuals. There is a growing awareness that glycemic efficacy of anti-diabetic dru...

Source: Cardiovascular Diabetology - February 2, 2017 Category: Cardiology Authors: James Xu and Rohan Rajaratnam Source Type: research